Publications

Minister’s Advisory Committee on Health : terms of reference

Description

Sets out the terms of reference for the Minister’s Advisory Committee on Health, which was established to provide input and recommendations to the Minister of Health and Wellness on legislative... More ≫

Description

Sets out the terms of reference for the Minister’s Advisory Committee on Health, which was established to provide input and recommendations to the Minister of Health and Wellness on legislative reforms to update current health legislation in a manner that will facilitate current and future health system initiatives.

Tags

Pandemic response governance framework

Description

Following the declaration by the World Health Organization of the spread of the H1N1 virus as a global pandemic in the first half of 2009, Alberta Health and Wellness contracted a consulting firm... More ≫

Description

Following the declaration by the World Health Organization of the spread of the H1N1 virus as a global pandemic in the first half of 2009, Alberta Health and Wellness contracted a consulting firm to assist in the development of a governance model to enable timely cross-ministry decision-making during a pandemic response. A number of stakeholders were interviewed and two governance models were reviewed. This report presents a recommended pandemic response governance model which is adapted from the strengths of the two models under review.

Tags

Photodynamic therapy for the treatment of Barrett’s esophagus : a systematic review and economic evaluation

Description

Barrett's esophagus is a benign condition, usually caused by long-term gastroesophageal reflux disease. In some individuals the abnormal Barrett's tissue develops precancerous cells. Barrett's... More ≫

Description

Barrett's esophagus is a benign condition, usually caused by long-term gastroesophageal reflux disease. In some individuals the abnormal Barrett's tissue develops precancerous cells. Barrett's esophagus with high grade dysplasia is associated with a higher risk of developing one type of esophageal cancer. Interventions to remove the dysplastic tissue are intended to reduce this risk. Photodynamic therapy is one of several less invasive, endoscopic treatment options for Barrett’s esophagus that offer an alternative to surgical removal of the esophagus. This review assesses the evidence on the safety and effectiveness of photodynamic therapy for the treatment of Barrett's esophagus with high grade dysplasia in comparison to esophagectomy and other endoscopic treatments for this condition. It also examines the social and economic considerations for the provision of PDT in comparison to alternate treatments.

Tags

After-action review of Alberta Health and Wellness response to H1N1 influenza

Description

This report outlines the lessons learned from the response to H1N1 Influenza and contains recommendations for improvements to the response capability of Alberta Health and Wellness and the... More ≫

Description

This report outlines the lessons learned from the response to H1N1 Influenza and contains recommendations for improvements to the response capability of Alberta Health and Wellness and the province as a whole. The report does not comment upon the merit of the public health system response itself, but rather provides recommendations for the improvement of the emergency management capability of Alberta Health and Wellness. The recommendations were based upon the findings of over 16 after-action reviews conducted with more than 70 individuals who were involved in Alberta’s response to the H1N1 Influenza virus.

Tags

Alberta pharmaceutical strategy [2009]

Description

Alberta Health and Wellness announced the creation of a Health Action Plan for Alberta in April 2008. A key component of this plan is the development of a pharmaceutical strategy. The majority of... More ≫

Description

Alberta Health and Wellness announced the creation of a Health Action Plan for Alberta in April 2008. A key component of this plan is the development of a pharmaceutical strategy. The majority of working Albertans are not covered by government-sponsored programs, and spending on drugs is increasing at a rate three times higher than that of physician or hospital services. To support the development of an Alberta Pharmaceutical Strategy, two consultations were undertaken in 2008. The Strategy outlined in this document is a response to the findings and recommendations of these consultations, and its goal is to make drug coverage more accessible, affordable, efficient and therapeutically effective.

Tags

Artificial disc arthroplasty (ACDA)

Description

Artificial cervical disc arthroplasty (ACDA) is a surgical procedure that may replace cervical fusion in selected patients suffering from cervical degenerative disc disease. The main outcome of... More ≫

Description

Artificial cervical disc arthroplasty (ACDA) is a surgical procedure that may replace cervical fusion in selected patients suffering from cervical degenerative disc disease. The main outcome of ACDA that sets it apart from fusion is the preservation of the spine mobility. The aim of this report is to review the literature for evidence of effectiveness and safety of the cervical artificial disks approved by Health Canada.

Tags

Alberta pharmaceutical strategy [2008]

Description

Alberta Health and Wellness announced the creation of a Health Action Plan for Alberta in April 2008. A key component of this plan is the development of a pharmaceutical strategy. The majority of... More ≫

Description

Alberta Health and Wellness announced the creation of a Health Action Plan for Alberta in April 2008. A key component of this plan is the development of a pharmaceutical strategy. The majority of working Albertans are not covered by government-sponsored programs, and spending on drugs is increasing at a rate three times higher than that of physician or hospital services. To support the development of an Alberta Pharmaceutical Strategy, two consultations were undertaken in 2008. The Strategy outlined in this document is a response to the findings and recommendations of these consultations, and its goal is to make drug coverage more accessible, affordable, efficient and therapeutically effective.

Tags

Alberta pharmaceutical strategy : stakeholder consultation

Description

A Health Action Plan for Alberta was announced by the Minister of Health and Wellness in April 2008. A key component of this plan is the development of a pharmaceutical strategy. A consultation... More ≫

Description

A Health Action Plan for Alberta was announced by the Minister of Health and Wellness in April 2008. A key component of this plan is the development of a pharmaceutical strategy. A consultation process was implemented to meet key stakeholders, summarize their comments, and make key recommendations. Meetings were held with 16 stakeholder groups representing patients, physicians, pharmacists, employers, benefit providers, and the pharmaceutical industry. Written submissions were also welcomed. This document summarizes the stakeholders input and presents 10 recommendations for the government to implement.

Tags

Alberta diagnostic imaging reporting requirement data standard. Version 0.1

Description

2008 data standard to define Alberta diagnostic imaging reporting requirements to support interoperability of DI reports across the province. It aligns with the DITR and DI message specifications.

Tags

Diagnostic imaging HL7 message specifications. Version 0.1

Description

2008 messaging standard for sharing of diagnostic imaging information across the provincial health system using HL7 v2.3. This includes both a message structure and vocabulary. The summary... More ≫

Description

2008 messaging standard for sharing of diagnostic imaging information across the provincial health system using HL7 v2.3. This includes both a message structure and vocabulary. The summary document outlines all materials in the message specifications which are included in the documentation set file.

Tags